ID   FYN_HUMAN               Reviewed;         534 AA.
AC   P06241-2;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-OCT-2022, entry version 264.
DE   RecName: Full=Isoform 2 of Tyrosine-protein kinase Fyn;
DE            EC=2.7.10.2;
DE   AltName: Full=Proto-oncogene Syn;
DE   AltName: Full=Proto-oncogene c-Fyn;
DE   AltName: Full=Src-like kinase;
DE            Short=SLK;
DE   AltName: Full=p59-Fyn;
GN   Name=FYN;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3099169; DOI=10.1128/mcb.6.12.4195-4201.1986;
RA   Kawakami T., Pennington C.Y., Robbins K.C.;
RT   "Isolation and oncogenic potential of a novel human src-like gene.";
RL   Mol. Cell. Biol. 6:4195-4201(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=3526330; DOI=10.1073/pnas.83.15.5459;
RA   Semba K., Nishizawa M., Miyajima N., Yoshida M.C., Sukegawa J.,
RA   Yamanashi Y., Sasaki M., Yamamoto T., Toyoshima K.;
RT   "Yes-related protooncogene, syn, belongs to the protein-tyrosine kinase
RT   family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:5459-5463(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND FUNCTION.
RC   TISSUE=T-cell;
RX   PubMed=7822789;
RA   Rigley K., Slocombe P., Proudfoot K., Wahid S., Mandair K., Bebbington C.;
RT   "Human p59fyn(T) regulates OKT3-induced calcium influx by a mechanism
RT   distinct from PIP2 hydrolysis in Jurkat T cells.";
RL   J. Immunol. 154:1136-1145(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in vitro-
RT   expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   MYRISTOYLATION AT GLY-2, AND PHOSPHORYLATION AT TYR-531.
RX   PubMed=1699196;
RA   Peters D.J., McGrew B.R., Perron D.C., Liptak L.M., Laudano A.P.;
RT   "In vivo phosphorylation and membrane association of the fyn proto-oncogene
RT   product in IM-9 human lymphoblasts.";
RL   Oncogene 5:1313-1319(1990).
RN   [9]
RP   DEPHOSPHORYLATION AT TYR-531 BY PTPRC.
RX   PubMed=1533589; DOI=10.1002/eji.1830220510;
RA   Mustelin T., Pessa-Morikawa T., Autero M., Gassmann M., Andersson L.C.,
RA   Gahmberg C.G., Burn P.;
RT   "Regulation of the p59fyn protein tyrosine kinase by the CD45
RT   phosphotyrosine phosphatase.";
RL   Eur. J. Immunol. 22:1173-1178(1992).
RN   [10]
RP   INTERACTION WITH PIK3R1.
RX   PubMed=8394019; DOI=10.1073/pnas.90.15.7366;
RA   Prasad K.V., Janssen O., Kapeller R., Raab M., Cantley L.C., Rudd C.E.;
RT   "Src-homology 3 domain of protein kinase p59fyn mediates binding to
RT   phosphatidylinositol 3-kinase in T cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:7366-7370(1993).
RN   [11]
RP   PALMITOYLATION.
RX   PubMed=8206991; DOI=10.1016/s0021-9258(19)89447-4;
RA   Alland L., Peseckis S.M., Atherton R.E., Berthiaume L., Resh M.D.;
RT   "Dual myristylation and palmitylation of Src family member p59fyn affects
RT   subcellular localization.";
RL   J. Biol. Chem. 269:16701-16705(1994).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF CD28.
RX   PubMed=7568038; DOI=10.1073/pnas.92.19.8891;
RA   Raab M., Cai Y.C., Bunnell S.C., Heyeck S.D., Berg L.J., Rudd C.E.;
RT   "p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase,
RT   growth factor receptor-bound protein GRB-2, and T cell-specific protein-
RT   tyrosine kinase ITK: implications for T-cell costimulation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8891-8895(1995).
RN   [13]
RP   INTERACTION WITH KIT.
RX   PubMed=9038210; DOI=10.1074/jbc.272.9.5915;
RA   Price D.J., Rivnay B., Fu Y., Jiang S., Avraham S., Avraham H.;
RT   "Direct association of Csk homologous kinase (CHK) with the
RT   diphosphorylated site Tyr568/570 of the activated c-KIT in
RT   megakaryocytes.";
RL   J. Biol. Chem. 272:5915-5920(1997).
RN   [14]
RP   INTERACTION WITH NEDD9.
RX   PubMed=9360983; DOI=10.1074/jbc.272.46.29083;
RA   Tachibana K., Urano T., Fujita H., Ohashi Y., Kamiguchi K., Iwata S.,
RA   Hirai H., Morimoto C.;
RT   "Tyrosine phosphorylation of Crk-associated substrates by focal adhesion
RT   kinase. A putative mechanism for the integrin-mediated tyrosine
RT   phosphorylation of Crk-associated substrates.";
RL   J. Biol. Chem. 272:29083-29090(1997).
RN   [15]
RP   INTERACTION WITH FYB1.
RC   TISSUE=Tonsil;
RX   PubMed=9207119; DOI=10.1073/pnas.94.14.7493;
RA   da Silva A.J., Li Z., de Vera C., Canto E., Findell P., Rudd C.E.;
RT   "Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-
RT   containing leukocyte protein 76 and modulates interleukin 2 production.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7493-7498(1997).
RN   [16]
RP   INTERACTION WITH CAV1.
RX   PubMed=9741627; DOI=10.1016/s0092-8674(00)81604-9;
RA   Wary K.K., Mariotti A., Zurzolo C., Giancotti F.G.;
RT   "A requirement for caveolin-1 and associated kinase Fyn in integrin
RT   signaling and anchorage-dependent cell growth.";
RL   Cell 94:625-634(1998).
RN   [17]
RP   TISSUE SPECIFICITY, PHOSPHORYLATION, AND ALTERNATIVE SPLICING.
RX   PubMed=10196263; DOI=10.1128/jvi.73.5.3709-3717.1999;
RA   Weil R., Levraud J.P., Dodon M.D., Bessia C., Hazan U., Kourilsky P.,
RA   Israel A.;
RT   "Altered expression of tyrosine kinases of the Src and Syk families in
RT   human T-cell leukemia virus type 1-infected T-cell lines.";
RL   J. Virol. 73:3709-3717(1999).
RN   [18]
RP   INTERACTION WITH EPHA8.
RX   PubMed=10498895; DOI=10.1038/sj.onc.1202917;
RA   Choi S., Park S.;
RT   "Phosphorylation at Tyr-838 in the kinase domain of EphA8 modulates Fyn
RT   binding to the Tyr-615 site by enhancing tyrosine kinase activity.";
RL   Oncogene 18:5413-5422(1999).
RN   [19]
RP   INTERACTION WITH PAG1.
RX   PubMed=10790433; DOI=10.1084/jem.191.9.1591;
RA   Brdicka T., Pavlistova D., Bruyns E., Leo A., Korinek V., Angelisova P.,
RA   Scherer J., Shevchenko A., Shevchenko A., Hilgert I., Cerny J., Drbal K.,
RA   Kuramitsu Y., Horejsi V., Schraven B.;
RT   "Phosphoprotein associated with glycosphingolipid-enriched microdomains
RT   (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds
RT   the protein tyrosine kinase csk and is involved in regulation of T cell
RT   activation.";
RL   J. Exp. Med. 191:1591-1604(2000).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF VAV1.
RX   PubMed=11005864; DOI=10.1073/pnas.97.20.10923;
RA   Huang J., Tilly D., Altman A., Sugie K., Grey H.M.;
RT   "T-cell receptor antagonists induce Vav phosphorylation by selective
RT   activation of Fyn kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10923-10929(2000).
RN   [21]
RP   FUNCTION IN PHOSPHORYLATION OF SNCA.
RX   PubMed=11162638; DOI=10.1006/bbrc.2000.4253;
RA   Nakamura T., Yamashita H., Takahashi T., Nakamura S.;
RT   "Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125.";
RL   Biochem. Biophys. Res. Commun. 280:1085-1092(2001).
RN   [22]
RP   INTERACTION WITH HEV ORF3 PROTEIN (MICROBIAL INFECTION).
RX   PubMed=11518702; DOI=10.1074/jbc.m101546200;
RA   Korkaya H., Jameel S., Gupta D., Tyagi S., Kumar R., Zafrullah M.,
RA   Mazumdar M., Lal S.K., Xiaofang L., Sehgal D., Das S.R., Sahal D.;
RT   "The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and
RT   activates MAPK.";
RL   J. Biol. Chem. 276:42389-42400(2001).
RN   [23]
RP   FUNCTION.
RX   PubMed=11536198; DOI=10.1002/neu.1066;
RA   Wolf R.M., Wilkes J.J., Chao M.V., Resh M.D.;
RT   "Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte
RT   differentiation.";
RL   J. Neurobiol. 49:62-78(2001).
RN   [24]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12218089; DOI=10.4049/jimmunol.169.6.2813;
RA   Yasuda K., Nagafuku M., Shima T., Okada M., Yagi T., Yamada T., Minaki Y.,
RA   Kato A., Tani-Ichi S., Hamaoka T., Kosugi A.;
RT   "Fyn is essential for tyrosine phosphorylation of Csk-binding
RT   protein/phosphoprotein associated with glycolipid-enriched microdomains in
RT   lipid rafts in resting T cells.";
RL   J. Immunol. 169:2813-2817(2002).
RN   [25]
RP   FUNCTION IN PHOSPHORYLATION OF ARHGAP32.
RX   PubMed=12788081; DOI=10.1016/s0006-291x(03)00923-9;
RA   Taniguchi S., Liu H., Nakazawa T., Yokoyama K., Tezuka T., Yamamoto T.;
RT   "p250GAP, a neural RhoGAP protein, is associated with and phosphorylated by
RT   Fyn.";
RL   Biochem. Biophys. Res. Commun. 306:151-155(2003).
RN   [26]
RP   FUNCTION IN PHOSPHORYLATION OF TRPC6.
RX   PubMed=14761972; DOI=10.1074/jbc.m311274200;
RA   Hisatsune C., Kuroda Y., Nakamura K., Inoue T., Nakamura T., Michikawa T.,
RA   Mizutani A., Mikoshiba K.;
RT   "Regulation of TRPC6 channel activity by tyrosine phosphorylation.";
RL   J. Biol. Chem. 279:18887-18894(2004).
RN   [27]
RP   FUNCTION.
RX   PubMed=15557120; DOI=10.1083/jcb.200405053;
RA   Meriane M., Tcherkezian J., Webber C.A., Danek E.I., Triki I.,
RA   McFarlane S., Bloch-Gallego E., Lamarche-Vane N.;
RT   "Phosphorylation of DCC by Fyn mediates Netrin-1 signaling in growth cone
RT   guidance.";
RL   J. Cell Biol. 167:687-698(2004).
RN   [28]
RP   FUNCTION IN PHOSPHORYLATION OF WAS.
RX   PubMed=14707117; DOI=10.1084/jem.20030976;
RA   Badour K., Zhang J., Shi F., Leng Y., Collins M., Siminovitch K.A.;
RT   "Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein
RT   (WASp) tyrosine phosphorylation is required for coupling T cell antigen
RT   receptor engagement to WASp effector function and T cell activation.";
RL   J. Exp. Med. 199:99-112(2004).
RN   [29]
RP   INTERACTION WITH UNC119.
RX   PubMed=14757743; DOI=10.1084/jem.20030589;
RA   Gorska M.M., Stafford S.J., Cen O., Sur S., Alam R.;
RT   "Unc119, a novel activator of Lck/Fyn, is essential for T cell
RT   activation.";
RL   J. Exp. Med. 199:369-379(2004).
RN   [30]
RP   REVIEW ON FUNCTION.
RX   PubMed=15489916; DOI=10.1038/sj.onc.1208074;
RA   Palacios E.H., Weiss A.;
RT   "Function of the Src-family kinases, Lck and Fyn, in T-cell development and
RT   activation.";
RL   Oncogene 23:7990-8000(2004).
RN   [31]
RP   FUNCTION IN PHOSPHORYLATION OF MAP2.
RX   PubMed=15536091; DOI=10.1074/jbc.m411380200;
RA   Zamora-Leon S.P., Bresnick A., Backer J.M., Shafit-Zagardo B.;
RT   "Fyn phosphorylates human MAP-2c on tyrosine 67.";
RL   J. Biol. Chem. 280:1962-1970(2005).
RN   [32]
RP   PHOSPHORYLATION AT THR-12, AND SUBCELLULAR LOCATION.
RX   PubMed=15537652; DOI=10.1074/jbc.m402053200;
RA   He Z., Cho Y.Y., Ma W.Y., Choi H.S., Bode A.M., Dong Z.;
RT   "Regulation of ultraviolet B-induced phosphorylation of histone H3 at
RT   serine 10 by Fyn kinase.";
RL   J. Biol. Chem. 280:2446-2454(2005).
RN   [33]
RP   INTERACTION WITH ITCH, AND FUNCTION.
RX   PubMed=16387660; DOI=10.1016/j.molcel.2005.11.014;
RA   Yang C., Zhou W., Jeon M.S., Demydenko D., Harada Y., Zhou H., Liu Y.C.;
RT   "Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated
RT   tyrosine phosphorylation.";
RL   Mol. Cell 21:135-141(2006).
RN   [34]
RP   FUNCTION IN PHOSPHORYLATION OF AGAP2.
RX   PubMed=16841086; DOI=10.1038/sj.cdd.4402011;
RA   Tang X., Feng Y., Ye K.;
RT   "Src-family tyrosine kinase fyn phosphorylates phosphatidylinositol 3-
RT   kinase enhancer-activating Akt, preventing its apoptotic cleavage and
RT   promoting cell survival.";
RL   Cell Death Differ. 14:368-377(2007).
RN   [35]
RP   INTERACTION WITH PRMT8.
RX   PubMed=17925405; DOI=10.1074/jbc.m704650200;
RA   Sayegh J., Webb K., Cheng D., Bedford M.T., Clarke S.G.;
RT   "Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its
RT   N-terminal domain.";
RL   J. Biol. Chem. 282:36444-36453(2007).
RN   [36]
RP   FUNCTION IN PHOSPHORYLATION OF CTNND1.
RX   PubMed=17194753; DOI=10.1128/mcb.01974-06;
RA   Castano J., Solanas G., Casagolda D., Raurell I., Villagrasa P.,
RA   Bustelo X.R., Garcia de Herreros A., Dunach M.;
RT   "Specific phosphorylation of p120-catenin regulatory domain differently
RT   modulates its binding to RhoA.";
RL   Mol. Cell. Biol. 27:1745-1757(2007).
RN   [37]
RP   FUNCTION IN PHOSPHORYLATION OF PAG1.
RX   PubMed=18056706; DOI=10.1074/jbc.m705215200;
RA   Solheim S.A., Torgersen K.M., Tasken K., Berge T.;
RT   "Regulation of FynT function by dual domain docking on PAG/Cbp.";
RL   J. Biol. Chem. 283:2773-2783(2008).
RN   [38]
RP   FUNCTION IN PHOSPHORYLATION OF KIRREL1.
RX   PubMed=18258597; DOI=10.1074/jbc.m707247200;
RA   Harita Y., Kurihara H., Kosako H., Tezuka T., Sekine T., Igarashi T.,
RA   Hattori S.;
RT   "Neph1, a component of the kidney slit diaphragm, is tyrosine-
RT   phosphorylated by the Src family tyrosine kinase and modulates
RT   intracellular signaling by binding to Grb2.";
RL   J. Biol. Chem. 283:9177-9186(2008).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND TYR-531, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [42]
RP   INTERACTION WITH FASLG.
RX   PubMed=19807924; DOI=10.1186/1471-2172-10-53;
RA   Voss M., Lettau M., Janssen O.;
RT   "Identification of SH3 domain interaction partners of human FasL (CD178) by
RT   phage display screening.";
RL   BMC Immunol. 10:53-53(2009).
RN   [43]
RP   FUNCTION IN PHOSPHORYLATION OF NPHS1.
RX   PubMed=19179337; DOI=10.1074/jbc.m806851200;
RA   Harita Y., Kurihara H., Kosako H., Tezuka T., Sekine T., Igarashi T.,
RA   Ohsawa I., Ohta S., Hattori S.;
RT   "Phosphorylation of nephrin triggers Ca2+ signaling by recruitment and
RT   activation of phospholipase C-{gamma}1.";
RL   J. Biol. Chem. 284:8951-8962(2009).
RN   [44]
RP   FUNCTION IN PHOSPHORYLATION OF DPYSL2.
RX   PubMed=19652227; DOI=10.1074/jbc.m109.000240;
RA   Uchida Y., Ohshima T., Yamashita N., Ogawara M., Sasaki Y., Nakamura F.,
RA   Goshima Y.;
RT   "Semaphorin3A signaling mediated by Fyn-dependent tyrosine phosphorylation
RT   of collapsin response mediator protein 2 at tyrosine 32.";
RL   J. Biol. Chem. 284:27393-27401(2009).
RN   [45]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [46]
RP   FUNCTION IN PTK2B/PYK2 PHOSPHORYLATION.
RX   PubMed=20028775; DOI=10.1189/jlb.0409227;
RA   Collins M., Tremblay M., Chapman N., Curtiss M., Rothman P.B.,
RA   Houtman J.C.;
RT   "The T cell receptor-mediated phosphorylation of Pyk2 tyrosines 402 and 580
RT   occurs via a distinct mechanism than other receptor systems.";
RL   J. Leukoc. Biol. 87:691-701(2010).
RN   [47]
RP   FUNCTION, AND INTERACTION WITH RUNX3.
RX   PubMed=20100835; DOI=10.1074/jbc.m109.071381;
RA   Goh Y.M., Cinghu S., Hong E.T., Lee Y.S., Kim J.H., Jang J.W., Li Y.H.,
RA   Chi X.Z., Lee K.S., Wee H., Ito Y., Oh B.C., Bae S.C.;
RT   "Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the
RT   protein in the cytoplasm.";
RL   J. Biol. Chem. 285:10122-10129(2010).
RN   [48]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [49]
RP   FUNCTION IN TCR SIGNALING, PHOSPHORYLATION, AND DEPHOSPHORYLATION AT
RP   TYR-420 BY PTPN2.
RX   PubMed=22080863; DOI=10.1172/jci59492;
RA   Wiede F., Shields B.J., Chew S.H., Kyparissoudis K., van Vliet C.,
RA   Galic S., Tremblay M.L., Russell S.M., Godfrey D.I., Tiganis T.;
RT   "T cell protein tyrosine phosphatase attenuates T cell signaling to
RT   maintain tolerance in mice.";
RL   J. Clin. Invest. 121:4758-4774(2011).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-26, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [51]
RP   INTERACTION WITH FYB2 AND FYB1.
RX   PubMed=27335501; DOI=10.4049/jimmunol.1501913;
RA   Jung S.H., Yoo E.H., Yu M.J., Song H.M., Kang H.Y., Cho J.Y., Lee J.R.;
RT   "ARAP, a novel adaptor protein, is required for TCR signaling and integrin-
RT   mediated adhesion.";
RL   J. Immunol. 197:942-952(2016).
RN   [52]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF SH3 DOMAIN.
RX   PubMed=7687536; DOI=10.2210/pdb1shf/pdb;
RA   Noble M.E.M., Musacchio A., Saraste M., Courtneidge S.A., Wierenga R.K.;
RT   "Crystal structure of the SH3 domain in human Fyn; comparison of the three-
RT   dimensional structures of SH3 domains in tyrosine kinases and spectrin.";
RL   EMBO J. 12:2617-2624(1993).
RN   [53]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 81-142.
RX   PubMed=7664083; DOI=10.1038/nsb0894-546;
RA   Musacchio A., Saraste M., Wilmanns M.;
RT   "High-resolution crystal structures of tyrosine kinase SH3 domains
RT   complexed with proline-rich peptides.";
RL   Nat. Struct. Biol. 1:546-551(1994).
RN   [54]
RP   STRUCTURE BY NMR.
RX   PubMed=8961927; DOI=10.1021/bi9620969;
RA   Renzoni D.A., Pugh D.J., Siligardi G., Das P., Morton C.J., Rossi C.,
RA   Waterfield M.D., Campbell I.D., Ladbury J.E.;
RT   "Structural and thermodynamic characterization of the interaction of the
RT   SH3 domain from Fyn with the proline-rich binding site on the p85 subunit
RT   of PI3-kinase.";
RL   Biochemistry 35:15646-15653(1996).
RN   [55]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 85-141 IN COMPLEX WITH NEF.
RX   PubMed=8681387; DOI=10.1016/s0092-8674(00)81276-3;
RA   Lee C.H., Saksela K., Mirza U.A., Chait B.T., Kuriyan J.;
RT   "Crystal structure of the conserved core of HIV-1 Nef complexed with a Src
RT   family SH3 domain.";
RL   Cell 85:931-942(1996).
RN   [56]
RP   STRUCTURE BY NMR OF SH3 DOMAIN.
RX   PubMed=8805554; DOI=10.1016/s0969-2126(96)00076-7;
RA   Morton C.J., Pugh D.J.R., Brown E.L.J., Kahmann J.D., Renzoni D.A.C.,
RA   Campbell I.D.;
RT   "Solution structure and peptide binding of the SH3 domain from human Fyn.";
RL   Structure 4:705-714(1996).
RN   [57]
RP   STRUCTURE BY NMR OF SH2 DOMAIN.
RX   PubMed=9351806; DOI=10.1016/s0969-2126(97)00283-9;
RA   Mulhern T.D., Shaw G.L., Morton C.J., Day A.J., Campbell I.D.;
RT   "The SH2 domain from the tyrosine kinase Fyn in complex with a
RT   phosphotyrosyl peptide reveals insights into domain stability and binding
RT   specificity.";
RL   Structure 5:1313-1323(1997).
RN   [58]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 84-144 IN COMPLEX WITH SLAMF1 AND
RP   SH2D1A.
RX   PubMed=12545174; DOI=10.1038/ncb920;
RA   Chan B., Lanyi A., Song H.K., Griesbach J., Simarro-Grande M., Poy F.,
RA   Howie D., Sumegi J., Terhorst C., Eck M.J.;
RT   "SAP couples Fyn to SLAM immune receptors.";
RL   Nat. Cell Biol. 5:155-160(2003).
RN   [59]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-243; ARG-410 AND GLU-506.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=B;
CC         IsoId=P06241-1; Sequence=Displayed;
CC       Name=2; Synonyms=T;
CC         IsoId=P06241-2; Sequence=VSP_024110;
CC       Name=3;
CC         IsoId=P06241-3; Sequence=VSP_024108;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   CCDS; CCDS5095.1; -.
DR   RefSeq; NP_694592.1; NM_153047.3.
DR   ProteomicsDB; 51878; -.
DR   Ensembl; ENST00000368678.8; ENSP00000357667.4; ENSG00000010810.17.
DR   Ensembl; ENST00000368682.7; ENSP00000357671.3; ENSG00000010810.17.
DR   Ensembl; ENST00000538466.5; ENSP00000440646.1; ENSG00000010810.17.
DR   Proteomes; UP000005640; Chromosome 6.
PE   1: Evidence at protein level;
SQ   SEQUENCE   534 AA;  60141 MW;  FA082D40A24C2802 CRC64;
     MGCVQCKDKE ATKLTEERDG SLNQSSGYRY GTDPTPQHYP SFGVTSIPNY NNFHAAGGQG
     LTVFGGVNSS SHTGTLRTRG GTGVTLFVAL YDYEARTEDD LSFHKGEKFQ ILNSSEGDWW
     EARSLTTGET GYIPSNYVAP VDSIQAEEWY FGKLGRKDAE RQLLSFGNPR GTFLIRESET
     TKGAYSLSIR DWDDMKGDHV KHYKIRKLDN GGYYITTRAQ FETLQQLVQH YSEKADGLCF
     NLTVIASSCT PQTSGLAKDA WEVARRSLCL EKKLGQGCFA EVWLGTWNGN TKVAIKTLKP
     GTMSPESFLE EAQIMKKLKH DKLVQLYAVV SEEPIYIVTE YMNKGSLLDF LKDGEGRALK
     LPNLVDMAAQ VAAGMAYIER MNYIHRDLRS ANILVGNGLI CKIADFGLAR LIEDNEYTAR
     QGAKFPIKWT APEAALYGRF TIKSDVWSFG ILLTELVTKG RVPYPGMNNR EVLEQVERGY
     RMPCPQDCPI SLHELMIHCW KKDPEERPTF EYLQSFLEDY FTATEPQYQP GENL
//
